NCT00030615View on ClinicalTrials.gov

Decitabine in Treating Patients With Advanced Solid Tumors

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

December 31, 2001

Primary Completion Date

September 30, 2008

Conditions
Male Breast CancerRecurrent Bladder CancerRecurrent Breast CancerRecurrent MelanomaStage III MelanomaStage IV Bladder CancerStage IV Breast CancerStage IV MelanomaUnspecified Adult Solid Tumor, Protocol Specific
Interventions
DRUG

decitabine

Given IV

OTHER

pharmacological study

Correlative studies

OTHER

laboratory biomarker analysis

Correlative studies

Trial Locations (1)

90033-0804

University of Southern California, Los Angeles

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00030615 - Decitabine in Treating Patients With Advanced Solid Tumors | Biotech Hunter | Biotech Hunter